QT
XENT

Quantbot Technologies’s Intersect ENT, Inc XENT Stock Holding History

Quantbot Technologies’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20
Closed – – 1751
2020
Q2 		$0 Sell
20
-4,808
-100% -$55.9K ﹤0.01% 1540
2020
Q1 		$57K Buy
4,828
+4,728
+4,728% +$105K 0.04% 414
2019
Q4 		$2K Sell
100
-4,864
-98% -$98.6K ﹤0.01% 1155
2019
Q3 		$84K Sell
4,964
-1,885
-28% -$34.3K 0.01% 870
2019
Q2 		$155K Buy
+6,849
New +$185K 0.02% 652
2017
Q4 		– Sell
-3,036
Closed -$94K – 1566
2017
Q3 		$94K Buy
3,036
+2,094
+222% +$62K 0.01% 854
2017
Q2 		$26K Buy
+942
New +$21.3K ﹤0.01% 980
2016
Q2 		– Sell
-100
Closed -$1K – 1453
2016
Q1 		$1K Buy
+100
New +$1.81K ﹤0.01% 1110
2015
Q3 		– Sell
-3,069
Closed -$87K – 1496
2015
Q2 		$87K Buy
+3,069
New +$80.4K 0.02% 683

Other funds holding XENT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Quantbot Technologies's XENT Position: Q3 2020 in Review

Quantbot Technologies sold out of Intersect ENT, Inc (XENT) in Q3 2020, closing a stake of 20 shares.

Quantbot Technologies first reported a position in XENT in Q2 2015 and held it in 9 quarters. The position peaked at $155K in Q2 2019. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2020.

  • Quantbot Technologies reported no remaining Intersect ENT, Inc position as of Q3 2020 after selling out during the quarter.
  • Quantbot Technologies sold 20 Intersect ENT, Inc shares in Q3 2020.
  • Quantbot Technologies first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 9 quarters.
  • Quantbot Technologies's Intersect ENT, Inc position peaked at $155K in Q2 2019.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2020.

Based on Quantbot Technologies's 13F filing for Q3 2020, filed 16 Nov 2020.